Wescoe Lecture Series
Our Wescoe Lecture Series offers patients, care partners, and healthcare professionals the opportunity to stay informed about the latest developments in pulmonary fibrosis patient care. Held throughout the year, these virtual sessions feature leading expert speakers covering a range of topics, from treatment updates and clinical trials to wellness strategies and patient resources. Participants gain valuable knowledge, practical tools, and a sense of connection within the pulmonary fibrosis community.
April & May 2026 Seminar
First Lecture: PPF & IPF: Unpacking the Alphabet Soup of Pulmonary Fibrosis
Date: Wednesday, April 22nd, 2026
Time: 1:00 – 2:30 PM ET
Presented by: Lisa Lancaster, MD – Chief Medical Officer Endeavor BioMedicines, Medical Director of the Interstitial Lung Disease Program and Associate Professor of Medicine at Vanderbilt University
Second Lecture: MIST Clinical Trial: Studying the Inhaled Pirfenidone in the Treatment of Progressive Pulmonary Fibrosis
Date: Tuesday, May 5th, 2026
Time: 12:00 – 1:00 PM ET
Presented by: Rebecca Weaver, APRN – Senior Director, Clinical Development, Avalyn Pharma